Stock market today: Live updates
Traders work on the floor of the New York Stock Exchange (NYSE) as a picture of Vice President Kamala Harris…
J&J, Bristol Myers Squibb lose Medicare drug-price talks challenges
Jonathan Raa | Nurphoto | Getty Images A federal judge in New Jersey on Monday rejected Johnson & Johnson‘s and…
Bristol Myers Squibb (BMY) earnings Q1 2024
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman…
Merck, J&J, Bristol Myers Squibb CEOs face Senate drug price hearing
(L-R) Joaquin Duato, CEO of Johnson & Johnson, Robert Davis, CEO of Merck, and Chris Boerner, CEO of Bristol Myers…
Merck, J&J CEOs agree to testify in Senate hearing on drug prices
Sen. Bernie Sanders, I-Vt., holds his news conference with Sen. Ed Markey, D-Mass., in the Capitol on Thursday, January 25,…
Follow CEOs at the JPMorgan Healthcare Conference
CNBC’s Jim Cramer on Friday told investors what to watch for on Wall Street next week, highlighting JPMorgan‘s market-moving health-care…
Cramer names biopharma companies as industry mergers start to accrue
CNBC’s Jim Cramer on Friday pointed out the number of biopharma mergers and acquisitions that have closed or been announced…
Medicare drug price negotiations what’s ahead in 2024
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services (HHS)…
Bristol Myers Squibb to buy Karuna Therapeutics
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or…
Stocks making the biggest moves midday: NKE, RKLB, BMY, NTES
Check out the companies making headlines in midday trading. Nike , Foot Locker — Shares of Nike plummeted 10% after…
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion
Bristol Myers Squib on Friday agreed to buy Karuna Therapeutics for $14 billion in cash, gaining a promising experimental schizophrenia…
Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and…
Jim Cramer explains why it’s hard to be bullish on healthcare
CNBC’s Jim Cramer on Thursday told investors why it’s hard to be bullish about healthcare stocks, citing challenges stemming from…
Top Wall Street analysts favor these five dividend stocks during
A sign bearing the logo for communications and security tech giant Cisco Systems Inc. is seen outside one of its…
Judge denies request to block
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January…
Most used drugs on Medicare price negotiation list: See the top 3
Bottles of the drug Jardiance, made by Eli Lilly and Company, sit on a counter at a pharmacy in Provo,…
Startups investing millions to make drugs and semiconductors in space
In-space manufacturing may sound like science fiction but it’s happening already, albeit on a very small scale. It’s a fledgling…